share_log

Senti Biosciences | 3: Initial statement of beneficial ownership of securities-Officer Li Yvonne

SEC announcement ·  May 10 04:27
Summary by Futu AI
Yvonne Li, the Interim CFO of Senti Biosciences, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated May 4, 2024, indicates that Li does not beneficially own any securities in the company. The form, signed by attorney-in-fact Mike Rhee on May 9, 2024, is a standard disclosure for officers, directors, and certain beneficial owners under Section 16(a) of the Securities Exchange Act of 1934. This filing is particularly relevant for investors as it provides transparency regarding the ownership stakes of key company insiders.
Yvonne Li, the Interim CFO of Senti Biosciences, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The filing, dated May 4, 2024, indicates that Li does not beneficially own any securities in the company. The form, signed by attorney-in-fact Mike Rhee on May 9, 2024, is a standard disclosure for officers, directors, and certain beneficial owners under Section 16(a) of the Securities Exchange Act of 1934. This filing is particularly relevant for investors as it provides transparency regarding the ownership stakes of key company insiders.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.